SFL (NYSE:SFL) Raised to “Buy” at StockNews.com
StockNews.com upgraded shares of SFL (NYSE:SFL – Free Report) from a hold rating to a buy rating in a report issued on Tuesday morning. Separately, BTIG Research increased their target price on SFL from $15.00 to $16.00 and gave the stock a buy rating in a research report on Tuesday, May 14th. Two analysts have […]
More Stories
Bone Biologics Co. (NASDAQ:BBLG) Short Interest Up 48.4% in October
Bone Biologics Co. (NASDAQ:BBLG – Get Free Report) saw a significant increase in short interest in October. As of October...
Biomerica, Inc. (NASDAQ:BMRA) Short Interest Update
Biomerica, Inc. (NASDAQ:BMRA – Get Free Report) saw a significant growth in short interest in the month of October. As...
Biora Therapeutics, Inc. (NASDAQ:BIOR) Sees Significant Increase in Short Interest
Biora Therapeutics, Inc. (NASDAQ:BIOR – Get Free Report) was the target of a significant increase in short interest during the...
Republicans Sue to Prevent Counting of Undated Ballots in Pennsylvania Senate Race
By Sam Dorman Republicans have asked the Pennsylvania Supreme Court to intervene in the state’s Senate race, alleging that several...
Insider Selling: MicroStrategy Incorporated (NASDAQ:MSTR) CAO Sells 752 Shares of Stock
MicroStrategy Incorporated (NASDAQ:MSTR – Get Free Report) CAO Jeanine Montgomery sold 752 shares of the firm’s stock in a transaction...
Head to Head Contrast: Neumora Therapeutics (NMRA) & Its Competitors
Neumora Therapeutics (NASDAQ:NMRA – Get Free Report) is one of 295 publicly-traded companies in the “Biological products, except diagnostic” industry,...